Part Details | CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
6505-01-126-1927
Alternate Parts: NDC52152001802, NDC52152-0018-02, NDC00677124701, NDC00677-1247-01, NDC00591400701, NDC00591-4007-01, NDC00603271421, NDC00603-2714-21, LIBRAX CAPSULES, LIBRAX, NDC00140000749, NDC00140-0007-49, NDC00904250360, NDC00904-2503-60, NDC00187410010, NDC00187-4100-10, 6505-01-126-1927, 01-126-1927, 6505011261927, 011261927
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | FEB 06, 1982 | 01-126-1927 | 26678 ( CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-126-1927
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC52152-0018-02 | 2X896 | AMIDE PHARMACEUTICAL INC |
| NDC00677-1247-01 | 59225 | BAXTER HEALTHCARE CORPBAXTER AIRLIFE/PHARMASEAL DIV |
| NDC00591-4007-01 | 62051 | DANBURY PHARMACAL INC |
| NDC00603-2714-21 | 0ET99 | GENERICS BIDCO I, LLCDBA PAR PHARMACEUTICAL |
| LIBRAX CAPSULES | 04493 | HOFFMANN-LA ROCHE INC. |
| LIBRAX | 04493 | HOFFMANN-LA ROCHE INC. |
| NDC00140-0007-49 | 04493 | HOFFMANN-LA ROCHE INC. |
| NDC00904-2503-60 | 0SYT3 | MAJOR PHARMACEUTICALS INC |
| NDC00187-4100-10 | 3AWU3 | VALEANT PHARMACEUTICALSINTERNATIONAL CORPORATION |
Technical Data | NSN 6505-01-126-1927
| Characteristic | Specifications |
|---|---|
| CAPSULE TYPE | |
| CAPSULE CONTENT FORM | |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE AND AB2.500 MILLIGRAMS CLIDINIUM BROMIDE |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER TYPE | STRIP |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 10.000 |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| FEATURES PROVIDED | INDIVIDUALLY SEALED |
| SUPPLEMENTARY FEATURES | MEDSEP ITEM FOR DOD,HOFFMANN-LA ROCHE INC |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LIBRAX CAPSULES 10 STRIPS OF 10 CAPSULES |